Metraipolis › archive › dc_1d3555d7affc

Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE) — Europe PMC PMID:41201892

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41201892
DOI
10.1128/aac.01325-25
License (as archived)
solo-consultazione
Archived
2026-11-08T17:49:35.770Z
SHA-256 of the archived text
c030bac381614b04c86e41f36dc210cdb1df9326795e23e3db79a91cf12d7678
Stable URL of this page
https://metraipolis.com/documento/dc_1d3555d7affc

How to cite

Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE) — Europe PMC PMID:41201892 — Europe PMC (en), https://europepmc.org/article/MED/41201892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1d3555d7affc (Metraipolis archive dc_1d3555d7affc, sha256 c030bac381614b04c86e41f36dc210cdb1df9326795e23e3db79a91cf12d7678)
BibTeX
@misc{dc1d3555d7affc,
  title = {Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE) — Europe PMC PMID:41201892},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41201892},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1d3555d7affc; sha256 c030bac381614b04c86e41f36dc210cdb1df9326795e23e3db79a91cf12d7678},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41201892. Agents can read the archived copy with the MCP tool read_document.